Pradžia › Limfoma › Washington › Seattle

Limfoma klinikiniai tyrimai Seattle, WA

12 tyrimai dėl Limfoma ieško dalyvių vietose Seattle ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

Renkami dalyviai2 fazė

Fred Hutchinson Cancer Center, Seattle

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07015242

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Renkami dalyviai2 fazė

Fred Hutchinson Cancer Center, Seattle

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-17 · NCT07221500

Collection of Tissue Samples for Cancer Research

Renkami dalyviaiStebimasis tyrimas

Fred Hutchinson, Seattle

2 Months · Visoms lytims · Atnaujinta 2026-09-16 · NCT00900198

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai

Seattle Children s Hospital, Seattle

Amžius 5 ir vyresni · Visoms lytims · Atnaujinta 2026-08-31 · NCT05237986

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

Renkami dalyviai1/2 fazė

Swedish Cancer Institute, Seattle
Fred Hutchinson Cancer Center, Seattle

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-19 · NCT04104776

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

Renkami dalyviai1 fazė

Fred Hutch Cancer Center, Seattle

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-17 · NCT06528301

DALY II USA/ MB-CART2019.1 for DLBCL

Renkami dalyviai2 fazė

Fred Hutchinson Cancer Center, Seattle

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-13 · NCT04792489

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Renkami dalyviai1/2 fazė

Dren Investigational Site, Seattle

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-17 · NCT05475925

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Renkami dalyviaiStebimasis tyrimas

Seattle Children's Hospital, Seattle

Visi amžiai · Visoms lytims · Atnaujinta 2026-05-18 · NCT01790152

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

Renkami dalyviai1/2 fazė

University of Washington Medical Center, Seattle

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-04-16 · NCT03328078

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Renkami dalyviai2 fazė

Fred Hutchinson Cancer Center, Seattle

Amžius nuo 18 iki 66 · Visoms lytims · Atnaujinta 2026-03-17 · NCT06859424

A Randomized Phase II Study Of Bruton Tyrosine Kinase Inhibitor With Or Without Venetoclax In Veterans With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

Renkami dalyviai2 fazė

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2025-10-14 · NCT06520098

Limfoma tyrimai kituose miestuose

Kiti tyrimai Seattle

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.